Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Endocrinology

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/EJE-13-0493PMID 23904280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombotic stroke and myocardial infarction with hormonal contraception.

  2012cited by this paper
• Long-term evaluation of cross-sex hormone treatment in transsexual persons.

  2012cited by this paper
• Obstetrical Management of Fulminant Viral Hepatitis in Late Pregnancy

  2012cited by this paper
• Comorbidities in Transsexual Patients under Hormonal Treatment Compared to Age- And Gender-Matched Primary Care Comparison Groups

  2012cited by this paper
• Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7

  2012cited by this paper
• ORIGINAL RESEARCH—INTERSEX AND GENDER IDENTITY DISORDERS Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons

  2012cited by this paper
• Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden

  2011cited by this paper
• Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy

  2011cited by this paper
• Clinical practice. Care of transsexual persons.

  2011cited by this paper
• Re: Safety of Physiological Testosterone Therapy in Women: Lessons From Female-to-Male Transsexuals (FMT) Treated With Pharmacological Testosterone Therapy.

  2011cited by this paper
• A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.

  2011influential reference
• Care of transsexual persons.

  2011cited by this paper
• Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.

  2010cited by this paper
• Hormonal therapy and sex reassignment: a systematic review and meta‐analysis of quality of life and psychosocial outcomes

  2010cited by this paper
• Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy.

  2010cited by this paper
• Hormonal contraception and risk of venous thromboembolism: national follow-up study

  2009cited by this paper
• Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance

  2009cited by this paper
• Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.

  2009cited by this paper
• Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis

  2008cited by this paper
• Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.

  2008cited by this paper
• Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females.

  2008cited by this paper
• Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.

  2008cited by this paper
• Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.

  2007cited by this paper
• Long-term follow-up: psychosocial outcome of Belgian transsexuals after sex reassignment surgery

  2006cited by this paper
• Brief report: Coronary heart disease events associated with hormone therapy in younger and older women

  2006cited by this paper
• Patient-Reported Complications and Functional Outcomes of Male-to-Female Sex Reassignment Surgery

  2006cited by this paper
• Female-to-male transgender quality of life

  2006cited by this paper
• Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

  2006cited by this paper
• Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects

  2003cited by this paper
• Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.

  2003cited by this paper
• Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

  2003cited by this paper
• Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study: Oral Contraceptives and the Risk of Ischemic Stroke

  2002cited by this paper
• Adolescents with gender identity disorder who were accepted or rejected for sex reassignment surgery: a prospective follow-up study.

  2001cited by this paper
• Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

  1999cited by this paper
• Mortality and morbidity in transsexual subjects treated with cross‐sex hormones

  1997influential reference
• Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study.

  1996cited by this paper
• Induction of insulin resistance by androgens and estrogens.

  1994cited by this paper
• Mortality and morbidity in transsexual patients with cross-gender hormone treatment.

  1989cited by this paper

• Sex steroids, SHBG and type 2 diabetes in women: what do we really know?

  2026cites this paper
• Multidisciplinary Breast Cancer Screening Algorithm in Transgender and Gender Diverse Populations

  2026cites this paper
• Adrenocortical tissue dynamics and corticosteroid perturbation upon the experimental male estrogenization: reflections from animal and in vitro data about human treatment

  2026cites this paper
• Case Report: Ischemic stroke in a young transgender woman due to unsupervised estrogen therapy

  2025cites this paper
• A review of menopause in transgender and gender diverse individuals

  2025cites this paper
• A Scoping Review Mapping Trans* and Gender Diverse People's Representation in Cancer Research

  2025influential citation
• Effect of testosterone on blood-clotting markers in transsexual men

  2025cites this paper
• Structure and hormonal output of the adrenal gland after experimental estrogenization of male rats.

  2025cites this paper
• Eating and exercise experiences of Australian trans and gender diverse folks: lived experience and stakeholder perspectives

  2025cites this paper
• Estradiol and dihydrotestosterone exert sex-specific effects on human fibroblast and endothelial proliferation, bioenergetics, and vasculogenesis

  2025cites this paper
• Contemporary Considerations for Breast Cancer Risk and Screening in Transgender, Nonbinary, and Gender-Diverse Populations

  2025cites this paper
• Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study.

  2025cites this paper
• Risk of venous thromboembolism in the transgender population on hormone therapy: A systematic review.

  2025cites this paper
• Perioperative Considerations for Transgender and Gender-Diverse Patients.

  2025cites this paper
• Navigating the Intersection of Hormonal Therapy and Acne Management in Trans Youth

  2025cites this paper
• Cardiovascular Health Disparities Among Sexual and Gender Minority Adults

  2025cites this paper
• Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association

  2025cites this paper
• Hematologists’ comfort and experiences with providing care to transgender youth

  2025cites this paper
• Hormone therapy and cancer risks in transgender people: a systematic review

  2025cites this paper
• Effetti metabolici delle terapie di affermazione di genere

  2025cites this paper
• Sex differences in blood pressure response to continuous acute Ang II infusion: are only sex hormones to blame?

  2025cites this paper
• Review of venous thromboembolism (VTE) risk, evaluation, and treatment in individuals on estrogen-based gender-affirming hormone therapy

  2025cites this paper
• Conceptualizing trans-inclusive healthcare in the United States: Environmental and interpersonal factors of healthcare provision

  2025cites this paper
• Current opinions invited review: testosterone and transgender medicine

  2025cites this paper
• Reporting of tobacco use and health outcomes among transgender and gender expansive people in gender-affirming hormone therapy research: 1980-2024.

  2025cites this paper
• Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies

  2025cites this paper
• Cerebrovascular Health Among Sex- and Gender-Diverse People

  2025cites this paper
• Treatment of Cardiovascular Manifestations in Transgender Individuals.

  2025cites this paper
• Thrombotic Risk Associated with Gender-Affirming Hormone Therapy.

  2024cites this paper
• High circulating concentrations of estradiol are anabolic for bone mass and strength in an adult male to female transgender mouse model.

  2024cites this paper
• Use of hormones and risk of venous thromboembolism

  2024cites this paper
• MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine

  2024influential citation
• Estrogen’s sex-specific effects on ischemic cell death and estrogen receptor mRNA expression in rat cortical organotypic explants

  2024cites this paper
• Gender-affirming hormone therapy and cardiovascular health in transgender adults

  2024cites this paper
• Metabolic and cardiovascular risks of hormone treatment for transgender individuals.

  2024cites this paper
• [Recommendations for Primary Health Care for transgender people].

  2024cites this paper
• Body Composition and Metabolic Syndrome Components in Transgender/Gender Diverse Adolescents and Young Adults

  2024cites this paper
• The impact of gender-affirming hormone therapy on nutrition-relevant biochemical measures

  2024cites this paper
• Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men

  2024cites this paper
• Cardiovascular disease in transgender people: a systematic review and meta-analysis.

  2024cites this paper
• A hormonioterapia e os riscos de câncer em pessoas transgênero: revisão sistemática

  2024cites this paper
• Uso de hormônios e risco de tromboembolismo venoso. Número 2 – 2024

  2024cites this paper
• Comparison of machine learning models for the prediction of hypertension in transgender patients undergoing gynecologic surgery

  2024cites this paper
• Transgender patients and gender-affirming hormone therapy through the mid-life.

  2024cites this paper
• Understanding risk of chronic pain development and related mental health disparities among transgender people: A review of current literature and future directions.

  2024cites this paper
• Transdermal oestradiol and exercise in androgen deprivation therapy (ESTRACISE): protocol

  2024cites this paper
• Body composition, metabolic syndrome, and lifestyle in treatment‐naïve gender‐diverse youth in Israel

  2024cites this paper
• Estradiol increases cortical and trabecular bone accrual and bone strength in an adolescent male-to-female mouse model of gender-affirming hormone therapy

  2024cites this paper
• Considerations for the care of transgender patients in orthopaedics and sports medicine: a narrative review

  2024influential citation
• Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia

  2024cites this paper
• Special Populations in Ambulatory Surgery: Oncologic, Lactating, Transgender and Gender Diverse, and Suicidal Ideation

  2024cites this paper
• Successful Treatment of Primary Mediastinal Large B-cell Lymphoma with DA-EPOCH-Rituximab Therapy in a Transgender Woman

  2023cites this paper
• Panorama global sociocultural y demográfico de la población trans y de género diverso en México: implicaciones en la salud cardíaca

  2023cites this paper
• A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health

  2023cites this paper
• Hemostatic considerations for gender affirming care.

  2023cites this paper
• Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy

  2023cites this paper
• Cognitive Impairment in Sexual and Gender Minority Groups: A Scoping Review of the Literature

  2023cites this paper
• A Cross-Sectional Analysis of Self-Reported Needs and Health Service Utilization Among Transgender Women in Lima, Perú

  2023cites this paper
• Estradiol Concentrations and Wellbeing in Trans People Using Estradiol Hormone Therapy

  2023cites this paper
• The Experience of HIV-Positive Transgender Women Engaging in Physical Activity: An Interpretative Phenomenological Analysis

  2023cites this paper
• Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays

  2023influential citation
• Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care

  2023cites this paper
• Transgender-related stigma and gender minority stress-related health disparities in Aotearoa New Zealand: hypercholesterolemia, hypertension, myocardial infarction, stroke, diabetes, and general health

  2023cites this paper
• Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults

  2023cites this paper
• The cardiovascular subtleties of testosterone on gender-affirming hormone therapy.

  2023cites this paper
• Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people.

  2023cites this paper
• Association of Current and Long-Term Estradiol Use with Carotid Intima Media Thickness Among Transgender Women: A Cross-Sectional Study

  2023cites this paper
• Assessing the Readability of Online Patient Education Resources Related to Neophallus Reconstruction.

  2023cites this paper
• Diabetes and Mental Health.

  2023cites this paper
• Perioperative Care of Transgender and Gender-Diverse Patients: A Biopsychosocial Approach

  2023cites this paper
• Cardiovascular disease and feminizing gender-affirming hormone therapy: Implications for the provision of safe and lifesaving care.

  2023cites this paper
• Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment

  2023cites this paper
• Transgender health and the impact of aging and menopause

  2023cites this paper
• Venous thromboembolism in transgender women

  2023cites this paper
• Analysis of Mortality Among Transgender and Gender Diverse Adults in England

  2023cites this paper
• Cardiovascular Risks Among the Transgender Population in Rural United States: Spotlight on the Appalachian Region

  2023cites this paper
• Cancer in Transgender and Gender-Diverse Persons: A Review.

  2023cites this paper
• Emergency Medicine Considerations in the Transgender Patient.

  2023cites this paper
• Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment

  2023cites this paper
• Perioperative Considerations for Gender-Affirming Surgery

  2023cites this paper
• Genetically predicted androgenic profiles and adverse cardiac markers: a sex‐specific Mendelian randomization study

  2023cites this paper
• Metabolic consequences of gender‐affirming hormone therapy in transgender adult persons

  2023cites this paper
• Effects of gender-affirming hormone therapy on cardiovascular risk factors focusing on glucose metabolism in an Austrian transgender cohort.

  2022cites this paper
• Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes

  2022cites this paper
• Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus

  2022cites this paper
• Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.

  2022cites this paper
• Repronormativität und reproduktive Gerechtigkeit – eine interdisziplinäre Analyse zur Fortpflanzung im Kontext von Trans

  2022cites this paper
• Chronic Kidney Disease in the Transgender, Nonbinary, or Gender Diverse Person.

  2022cites this paper
• Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults

  2022cites this paper
• Thrombophilia and hormonal therapy in transgender persons: A literature review and case series.

  2022cites this paper
• A Need for Greater Emphasis on 2SLGBTQIA+ Health Among Physiotherapists in Canada.

  2022cites this paper
• Gender- and Sexual Orientation- Based Inequities: Promoting Inclusion, Visibility, and Data Accuracy in Oncology.

  2022cites this paper
• What Cardiothoracic Radiologists Should Know About Imaging in Transgender Patients

  2022cites this paper
• Cardiac Mechanics in Altered Hormonal States as a Surrogate for Understanding the Effects of Transgender Hormone Therapy

  2022cites this paper
• Standards of Care for the Health of Transgender and Gender Diverse People, Version 8

  2022cites this paper
• Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy

  2022cites this paper
• “We Are Doing the Absolute Most That We Can, and No One Is Listening”: Barriers and Facilitators to Health Literacy within Transgender and Nonbinary Communities

  2022cites this paper
• Testosterone Use in the Perioperative Setting

  2022cites this paper
• Towards increasing equity in healthcare among transgender women: a cross-sectional analysis of self-reported needs and health service utilization in Lima, Peru

  2022cites this paper
• The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review

  2022cites this paper